Comprehensive clinical trial delivery across Phase I–III with a focus on quality and efficiency.
Bringing 25 years of strategic and operational leadership across global drug development and manufacturing enterprises, Chris has guided initiatives spanning the UK, EU, and US.
His expertise lies in crafting clear business and operational frameworks and inspiring high-performance teams in dynamic, solutions-driven environments. He is passionate about forging strong client partnerships and delivering impactful therapies that meaningfully improve patient outcomes. This client-centric approach has consistently fostered shared success and long-standing relationships. In each role,
Chris has demonstrated a commitment to culture, accountability, and empowerment. 360° feedback and engagement surveys frequently highlight his leadership, which is praised for authenticity, leading-by-example, and cultivating talent.
Chris’s track record includes steering CMC/biosafety teams in the UK, scaling operations across Ireland/EU, and most recently, advancing growth within a major US-based organisation.
No articles found for this topic.
